Roberti, Roberta
De Caro, Carmen
Iannone, Luigi Francesco
Zaccara, Gaetano
Lattanzi, Simona
Russo, Emilio http://orcid.org/0000-0002-1279-8123
Article History
Accepted: 20 April 2021
First Online: 16 May 2021
Declarations
:
: This manuscript was not funded.
: Emilio Russo has received speaker fees or funding from, and has participated in advisory boards for, Arvelle Therapeutics, Eisai, Pfizer, GW Pharmaceuticals, UCB and Lundbeck. Gaetano Zaccara has received speaker’s or consultancy fees from Eisai, UCB Pharma and Jazz Pharmaceuticals, and has served on the advisory board for GW Pharmaceuticals. Simona Lattanzi has received speaker’s or consultancy fees from Eisai, UCB Pharma, and GW Pharmaceuticals, and has served on advisory boards for GW Pharmaceuticals and Arvelle Therapeutics. Roberta Roberti, Carmen De Caro, Luigi F. Iannone have no conflicts of interest to declare.
: Data sharing is not applicable to this manuscript as no datasets were generated or analyzed.
: Not applicable.
: All authors participated equally in the conceptualization of the manuscript and in the writing up of the manuscript, from the initial draft to the final version. All authors have read and approved the final version.